| [1] |
Nomura R, Fujii H, Abe M, et al. Mesothelin expression is a prognostic factor in cholangiocellular carcinoma[J]. Int Surg, 2013, 98(2):164-169.
|
| [2] |
Hu C, Cheng C, Pan S, et al. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2[J]. Cell Signal, 2013, 25(6):1457-1467.
|
| [3] |
Jain K, Basu A. The multifunctional protein kinase C-ε in cancer development and progression[J]. Cancers, 2014, 6(2):860-878.
|
| [4] |
Körner C, Keklikoglou I, Bender C, et al. MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKC epsilon)[J]. J Biol Chem, 2013, 288(12):8750-8761.
|
| [5] |
Guo Y, Liang X, Lu M, et al. Mammalian target of rapamycin as a novel target in the treatment of hepatocellular carcinoma[J]. Hepatogastroenterology, 2009, 57(101):913-918.
|
| [6] |
Ye X, Guo Y, Zhang Q, et al. βKlotho suppresses tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3β/Cyclin D1 signaling pathway[J]. PloS One, 2013, 8(1):e55615.
|
| [7] |
Guo Y, Chen W, Wang W, et al. Simultaneous diagnosis and gene therapy of immuno-rejection in rat allogeneic heart transplantation model using a T-cell-targeted theranostic nanosystem[J]. ACS Nano, 2012, 6(12):10646-10657.
|
| [8] |
Wang J, Ou J, Guo Y, et al. TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer[J]. Br J Cancer, 2014, 111(1):112-124.
|
| [9] |
Wang C, Guo Y, Wang J, et al. The suppressive role of SOX7 in hepatocarcinogenesis[J]. PloS One, 2014, 9(5):e97433.
|
| [10] |
Diaz-Cueto L, Arechavaleta-Velasco F, Diaz-Arizaga A, et al. PKC signaling is involved in the regulation of progranulin (acrogranin/PC-cell-derived growth factor/granulin-epithelin precursor) protein expression in human ovarian cancer cell lines[J]. Int J Gynecol Cancer, 2012, 22(6):945-950.
|
| [11] |
Dudek H, Wong DH, Arvan R, et al. Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo[J]. Mol Ther, 2014, 22(1):92-101.
|
| [12] |
法镇中，江勇，谭玉林，等．慢病毒介导siRNA沉默EGFR基因及其对胰腺癌细胞增殖和凋亡的影响[J/CD]．中华肝脏外科手术学电子杂志，2013, 2(2):113-118.
|
| [13] |
Huang B, Cao K, Li X, et al. The expression and role of protein kinase C (PKC) epsilon in clear cell renal cell carcinoma[J]. J Exp Clin Cancer Res, 2011, 30(1):88.
|
| [14] |
Gobbi G, Masselli E, Micheloni C, et al. Hypoxia-induced down-modulation of PKCepsilon promotes trail-mediated apoptosis of tumor cells[J]. Int J Oncol, 2010, 37(3):719-729.
|
| [15] |
Chen J, Giridhar KV, Zhang L, et al. A protein kinase C/protein kinase D pathway protects LNCaP prostate cancer cells from phorbol ester-induced apoptosis by promoting ERK1/2 and NF-{kappa}B activities[J]. Carcinogenesis, 2011, 32(8):1198-1206.
|
| [16] |
Aziz MH, Shen H, Maki CG. Glucocorticoid receptor activation inhibits p53-induced apoptosis of MCF10Amyc cells via induction of protein kinase Cepsilon[J]. J Biol Chem, 2012, 287(35):29825-29836.
|
| [17] |
Abd EI-Hakim TF, El-Shafie MK, Abdou AG, et al. Value of urinary survivin as a diagnostic marker in bladder cancer[J]. Anal Quant Cytopathol Histpathol, 2014, 36(3):121-127.
|
| [18] |
Salzano G, Riehle R, Navarro G, et al. Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer[J]. Cancer Lett, 2014, 343(2):224-231.
|
| [19] |
Wenying Z, Zhaoning J, Zhimin Y, et al. Survivin siRNA inhibits gastric cancer in nude mice[J]. Cell Biochem Biophys, 2012, 62(2):337-341.
|